Skip to main content

Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD)

Publication ,  Conference
Poe, J; diPaolo, J; Jia, W; Kim, JY; Su, H; Reyes, N; Marcondes, AM; Saban, D; Cardona, D; Anand, S; Cardones, A; Chao, N; Sarantopoulos, S
Published in: BONE MARROW TRANSPLANTATION
July 1, 2017

Duke Scholars

Published In

BONE MARROW TRANSPLANTATION

EISSN

1476-5365

ISSN

0268-3369

Publication Date

July 1, 2017

Volume

52

Start / End Page

S46 / S46

Location

Marseille, FRANCE

Publisher

NATURE PUBLISHING GROUP

Conference Name

43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)

Related Subject Headings

  • Immunology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Poe, J., diPaolo, J., Jia, W., Kim, J. Y., Su, H., Reyes, N., … Sarantopoulos, S. (2017). Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD). In BONE MARROW TRANSPLANTATION (Vol. 52, pp. S46–S46). Marseille, FRANCE: NATURE PUBLISHING GROUP.
Poe, J., J. diPaolo, W. Jia, J. Y. Kim, H. Su, N. Reyes, A. M. Marcondes, et al. “Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD).” In BONE MARROW TRANSPLANTATION, 52:S46–S46. NATURE PUBLISHING GROUP, 2017.
Poe J, diPaolo J, Jia W, Kim JY, Su H, Reyes N, et al. Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD). In: BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2017. p. S46–S46.
Poe, J., et al. “Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD).” BONE MARROW TRANSPLANTATION, vol. 52, NATURE PUBLISHING GROUP, 2017, pp. S46–S46.
Poe J, diPaolo J, Jia W, Kim JY, Su H, Reyes N, Marcondes AM, Saban D, Cardona D, Anand S, Cardones A, Chao N, Sarantopoulos S. Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD). BONE MARROW TRANSPLANTATION. NATURE PUBLISHING GROUP; 2017. p. S46–S46.

Published In

BONE MARROW TRANSPLANTATION

EISSN

1476-5365

ISSN

0268-3369

Publication Date

July 1, 2017

Volume

52

Start / End Page

S46 / S46

Location

Marseille, FRANCE

Publisher

NATURE PUBLISHING GROUP

Conference Name

43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)

Related Subject Headings

  • Immunology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences